289 related articles for article (PubMed ID: 20064612)
1. The DNA methylome of glioblastoma multiforme.
Martinez R; Esteller M
Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic mechanisms in glioblastoma multiforme.
Nagarajan RP; Costello JF
Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
[TBL] [Abstract][Full Text] [Related]
3. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.
Drabycz S; Roldán G; de Robles P; Adler D; McIntyre JB; Magliocco AM; Cairncross JG; Mitchell JR
Neuroimage; 2010 Jan; 49(2):1398-405. PubMed ID: 19796694
[TBL] [Abstract][Full Text] [Related]
4. Association between response to primary treatments and MGMT status in glioblastoma.
Franceschi E; Tosoni A; Pozzati E; Brandes AA
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1781-6. PubMed ID: 18983238
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
[TBL] [Abstract][Full Text] [Related]
6. Diversity of cytogenetic and pathohistologic profiles in glioblastoma.
Hassler M; Seidl S; Fazeny-Doerner B; Preusser M; Hainfellner J; Rössler K; Prayer D; Marosi C
Cancer Genet Cytogenet; 2006 Apr; 166(1):46-55. PubMed ID: 16616111
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
[TBL] [Abstract][Full Text] [Related]
8. [Epigenetic regulation in glioblastomas].
Quillien V
Ann Pathol; 2009 Nov; 29 Spec No 1():S34-6. PubMed ID: 19887247
[No Abstract] [Full Text] [Related]
9. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme.
Martinez R; Setien F; Voelter C; Casado S; Quesada MP; Schackert G; Esteller M
Carcinogenesis; 2007 Jun; 28(6):1264-8. PubMed ID: 17272309
[TBL] [Abstract][Full Text] [Related]
10. An update on the epigenetics of glioblastomas.
Ferreira WA; Pinheiro Ddo R; Costa Junior CA; Rodrigues-Antunes S; Araújo MD; Leão Barros MB; Teixeira AC; Faro TA; Burbano RR; Oliveira EH; Harada ML; Borges Bdo N
Epigenomics; 2016 Sep; 8(9):1289-305. PubMed ID: 27585647
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic modulation of metabolism in glioblastoma.
Dong Z; Cui H
Semin Cancer Biol; 2019 Aug; 57():45-51. PubMed ID: 30205139
[TBL] [Abstract][Full Text] [Related]
12. Serum DNA as a tool for cancer patient management.
Ramirez JL; Taron M; Balaña C; Sarries C; Mendez P; de Aguirre I; Nuñez L; Roig B; Queralt C; Botia M; Rosell R
Rocz Akad Med Bialymst; 2003; 48():34-41. PubMed ID: 14737938
[TBL] [Abstract][Full Text] [Related]
13. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
Kunkle B; Yoo C; Roy D
Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
Bai Y; Zhang QG; Wang XH
Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217
[TBL] [Abstract][Full Text] [Related]
15. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
Eoli M; Menghi F; Bruzzone MG; De Simone T; Valletta L; Pollo B; Bissola L; Silvani A; Bianchessi D; D'Incerti L; Filippini G; Broggi G; Boiardi A; Finocchiaro G
Clin Cancer Res; 2007 May; 13(9):2606-13. PubMed ID: 17473190
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.
Cadieux B; Ching TT; VandenBerg SR; Costello JF
Cancer Res; 2006 Sep; 66(17):8469-76. PubMed ID: 16951158
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme.
Martinez R; Schackert G; Esteller M
J Neurooncol; 2007 Apr; 82(2):133-9. PubMed ID: 17048097
[TBL] [Abstract][Full Text] [Related]
18. Concordant methylation of the ER and N33 genes in glioblastoma multiforme.
Li Q; Jedlicka A; Ahuja N; Gibbons MC; Baylin SB; Burger PC; Issa JP
Oncogene; 1998 Jun; 16(24):3197-202. PubMed ID: 9671399
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival with glioblastoma multiforme.
Krex D; Klink B; Hartmann C; von Deimling A; Pietsch T; Simon M; Sabel M; Steinbach JP; Heese O; Reifenberger G; Weller M; Schackert G;
Brain; 2007 Oct; 130(Pt 10):2596-606. PubMed ID: 17785346
[TBL] [Abstract][Full Text] [Related]
20. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
Shamsara J; Sharif S; Afsharnezhad S; Lotfi M; Raziee HR; Ghaffarzadegan K; Moradi A; Rahighi S; Behravan J
Cancer Invest; 2009 Oct; 27(8):825-9. PubMed ID: 19544111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]